skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Female remover assunto: Treatment Outcome remover Time Factors remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014
Material Type:
Artigo 		Adicionar ao Meu Espaço

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014

Szummer, Karolina ; Wallentin, Lars ; Lindhagen, Lars ; Alfredsson, Joakim ; Erlinge, David ; Held, Claes ; James, Stefan ; Kellerth, Thomas ; Lindahl, Bertil ; Ravn-Fischer, Annica ; Rydberg, Erik ; Yndigegn, Troels ; Jernberg, Tomas

European heart journal, 2017-11, Vol.38 (41), p.3056-3065 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
12
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

Zhu, Andrew X, Dr ; Park, Joon Oh, MD ; Ryoo, Baek-Yeol, MD ; Yen, Chia-Jui, MD ; Poon, Ronnie, MD ; Pastorelli, Davide, MD ; Blanc, Jean-Frederic, MD ; Chung, Hyun Cheol, MD ; Baron, Ari D, MD ; Pfiffer, Tulio Eduardo Flesch, MD ; Okusaka, Takuji, MD ; Kubackova, Katerina, MD ; Trojan, Jorg, MD ; Sastre, Javier, PhD ; Chau, Ian, MD ; Chang, Shao-Chun, MD ; Abada, Paolo B, MD ; Yang, Ling, MS ; Schwartz, Jonathan D, MD ; Kudo, Masatoshi, MD

The lancet oncology, 2015-07, Vol.16 (7), p.859-870 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
13
Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial
Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial

Maio, Michele ; Grob, Jean-Jacques ; Aamdal, Steinar ; Bondarenko, Igor ; Robert, Caroline ; Thomas, Luc ; Garbe, Claus ; Chiarion-Sileni, Vanna ; Testori, Alessandro ; Chen, Tai-Tsang ; Tschaika, Marina ; Wolchok, Jedd D

Journal of clinical oncology, 2015-04, Vol.33 (10), p.1191-1196 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
14
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

Casulo, Carla ; Byrtek, Michelle ; Dawson, Keith L ; Zhou, Xiaolei ; Farber, Charles M ; Flowers, Christopher R ; Hainsworth, John D ; Maurer, Matthew J ; Cerhan, James R ; Link, Brian K ; Zelenetz, Andrew D ; Friedberg, Jonathan W

Journal of clinical oncology, 2015-08, Vol.33 (23), p.2516-2522 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
15
Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab
Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab

Raja, Rajiv ; Kuziora, Michael ; Brohawn, Philip Z ; Higgs, Brandon W ; Gupta, Ashok ; Dennis, Phillip A ; Ranade, Koustubh

Clinical cancer research, 2018-12, Vol.24 (24), p.6212-6222 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
16
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Iwata, Hiroji ; Chia, Stephen K L ; Bashford, Anna ; Inoue, Kenichi ; Armstrong, Anne C ; Wong, Alvin ; Buyse, Marc ; Harvey, Vernon ; Smith, John W. ; Konstantinovic, Zora Neskovic ; Rodriguez, Gladys I. ; Jáñez Martinez, Noelia ; Knoop, Ann Soegaard ; De Boer, Richard Hendry ; Rai, Yoshiaki ; Yamamoto, Naohito ; Brincat, Stephen ; Papish, Steven William ; Manalo, Yvonne ; Sorensen, Peter Grundtvig ; Aogi, Kenjiro ; Shimizu, Satoru ; Mainwaring, Paul ; Chang, Jose ; del Barco Berron, Sonia ; Dickerson, Laura C. ; Klein, Leonard M. ; Ruxer, Robert ; Veyret, Corinne ; Wagnerova, Maria ; Richards, Donald A. ; Vasileios, Asskikis ; Dourthe, Louis Marie ; Lu, Yen-Shen ; Greenspan, Andrew R. ; Gonzalez Santiago, Santiago ; Perren, Timothy John ; Yau, Chung Cheung Thomas ; Pikó, Béla ; Sato, Nobuaki ; Askoy, Sercan ; Altundag, Mustafa Kadri ; Saip, Pinar ; Bajaj, Rajesh ; Vestlev, Peter Michael ; Dank, Magdolna ; Cinieri, Saverio ; Suszko-Kazarnowicz, Malgorzata ; Yap, Yoon Sim ; Chen, Shin-Cheh ; Haley, Barbara Bacsik ; Inhorn, Roger C. ; Koynova, Tatyana ; Schneeweiss, Andreas ; Cubedo Cervera, Ricardo ; Urruticoechea Ribate, Ander ; Schwartz, Garry H. ; Mocharnuk, Robert Scott ; Alkhouri, Nabiel ; Erickson, Nicholette ; Traynor, Ann ; Volterra, Fabio ; Capo, Gerardo ; Flaherty, Lawrence E. ; Baidas, Said ; Lybaert, Willem ; Holland, David R. ; Gonzalez Jimenez, Sonia ; Vanlemmens, Laurence ; Ruggeri, Enzo Maria ; Desai, Ajit ; Nixon, David Allen ; O'Brien, Edward ; Lanier, Keith S. ; Brescia, Frankie Ann ; Richard, Vincent ; Geldhof, Kurt ; Bednarik, Otakar ; Schwedler, Kathrin ; Fries, Stefan ; Klare, Peter ; Griesinger, Frank ; Trufflandier, Nathalie ; Chetiyawardana, Anula D. ; Papandreou, Christos ; Hornyak, Lajos ; Simo, Erzsebet ; Im, Seock-Ah ; Ruit, Jan B. ; Ciltas, Aydin ; Benekli, Mustafa ; Conkright, William A. ; Ottaviano, Yvonne ; Delmas, Andrew ; Steele, Heather A. ; Bova, Abby R. ; Shirinian, Mihran ; O'Rourke, Timothy J. ; Francisco, Michael ; Carrillo Flores, Maria Regina

The lancet oncology, 2017-12, Vol.18 (12), p.1688-1700 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
17
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib

Byrd, John C. ; Furman, Richard R. ; Coutre, Steven E. ; Burger, Jan A. ; Blum, Kristie A. ; Coleman, Morton ; Wierda, William G. ; Jones, Jeffrey A. ; Zhao, Weiqiang ; Heerema, Nyla A. ; Johnson, Amy J. ; Shaw, Yun ; Bilotti, Elizabeth ; Zhou, Cathy ; James, Danelle F. ; O'Brien, Susan

Blood, 2015-04, Vol.125 (16), p.2497-2506 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
18
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Ribas, Antoni, Prof ; Puzanov, Igor, MD ; Dummer, Reinhard, Prof ; Schadendorf, Dirk, Prof ; Hamid, Omid, MD ; Robert, Caroline, Prof ; Hodi, F Stephen, MD ; Schachter, Jacob, Prof ; Pavlick, Anna C, MD ; Lewis, Karl D, MD ; Cranmer, Lee D, MD ; Blank, Christian U, MD ; O'Day, Steven J, MD ; Ascierto, Paolo A, Prof ; Salama, April K S, MD ; Margolin, Kim A, Prof ; Loquai, Carmen, MD ; Eigentler, Thomas K, MD ; Gangadhar, Tara C, MD ; Carlino, Matteo S, MBBS ; Agarwala, Sanjiv S, Prof ; Moschos, Stergios J, MD ; Sosman, Jeffrey A, Prof ; Goldinger, Simone M, MD ; Shapira-Frommer, Ronnie, MD ; Gonzalez, Rene, Prof ; Kirkwood, John M, Prof ; Wolchok, Jedd D, Prof ; Eggermont, Alexander, Prof ; Li, Xiaoyun Nicole, PhD ; Zhou, Wei, PhD ; Zernhelt, Adriane M, BS ; Lis, Joy, BSN ; Ebbinghaus, Scot, MD ; Kang, S Peter, MD ; Daud, Adil, Prof

The lancet oncology, 2015-08, Vol.16 (8), p.908-918 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
19
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

Kunkler, Ian H, Prof ; Williams, Linda J, PhD ; Jack, Wilma J L, MBChB ; Cameron, David A, Prof ; Dixon, J Michael, Prof

The lancet oncology, 2015-03, Vol.16 (3), p.266-273 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
20
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia

Etienne, Gabriel ; Guilhot, Joëlle ; Rea, Delphine ; Rigal-Huguet, Françoise ; Nicolini, Franck ; Charbonnier, Aude ; Guerci-Bresler, Agnès ; Legros, Laurence ; Varet, Bruno ; Gardembas, Martine ; Dubruille, Viviane ; Tulliez, Michel ; Noel, Marie-Pierre ; Ianotto, Jean-Christophe ; Villemagne, Bruno ; Carré, Martin ; Guilhot, François ; Rousselot, Philippe ; Mahon, François-Xavier

Journal of clinical oncology, 2017-01, Vol.35 (3), p.298-305 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (10.189)
  2. Revistas revisadas por pares (9.509)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (10.498)
  2. magazinearticle  (2)
  3. Anais de Congresso  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2005  (5)
  2. 2005Até2008  (516)
  3. 2009Até2012  (3.464)
  4. 2013Até2017  (6.126)
  5. Após 2017  (391)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (10.462)
  2. Japonês  (1.821)
  3. Português  (59)
  4. Russo  (13)
  5. Islândico  (10)
  6. Chinês  (7)
  7. Espanhol  (7)
  8. Húngaro  (5)
  9. Alemão  (5)
  10. Francês  (3)
  11. Lituano  (2)
  12. Galês  (1)
  13. Polonês  (1)
  14. Persa  (1)
  15. Tcheco  (1)
  16. Holandês  (1)
  17. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.